Loading viewer...
investor_presentation
Format: PDF investor_presentation
Geospace Technologies investor presentation dated February 2022.
Q1 FY2022 Presentation
February 2022Forward -Looking Statements
This presentation includes forward -looking statements within the meaning ofSection 21E ofthe Securities Exchange Act of1934, asamended, and
Section 27A ofthe Securities Act of1933, asamended. Allstatements other than statements ofhistorical facts included herein, including statements
regarding the Company’s future financial position and results ofoperations, future product development initiatives, the Company’s business strategy,
the future mix ofproduct revenues, future demand forthe Company’s products and general conditions inthe energy industry, ingeneral, and the
seismic industry, are forward -looking statements. These forward -looking statements are often identified byterminology such as“may”, “will”, “should”,
“could”, “intend”, “expect”, “plan”, “budget”, “forecast”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “continue”, “evaluating” orsimilar
words .Forward looking statements should beread carefully because they discuss our future expectations, contain projections ofour future results of
operations orofour financial position orstate other forward -looking information. Examples offorward -looking statements include, among others,
statements that wemake regarding our expected operating results, the adoption and sale ofour products invarious geographic regions, our ability to
diversify into non- O&G businesses, potential tenders forPRM systems, future demand forOBX systems, the completion ofnew orders forchannels ofour
GCL system, the fulfillment ofcustomer payment obligations, the availability offinancing under our credit facility, the impact ofthe coronavirus (or
COVID -19) pandemic, the Company’s ability tomanage changes and the continued health oravailability ofmanagement personnel, volatility and
direction ofoilprices, anticipated levels ofcapital expenditures and the sources offunding therefore, and our strategy forgrowth, product development,
market position, financial results and the provision ofaccounting reserves .These forward -looking statements reflect our current judgment about future
events and trends based onthe information currently available tous.However, there will likely beevents inthe future that weare not able topredict or
control .The factors listed under the caption “Risk Factors” and elsewhere inour most recent Annual Report onForm 10-K,which isonfile with the
Securities and Exchange Commission, aswell asother cautionary language inany subsequent Quarterly Report onForm 10-Q,orinour other periodic
reports, provide examples ofrisks, uncertainties and events that may cause our actual results todiffer materially from the expectations wedescribe in
our forward -looking statements. Such examples include, but are not limited to,continued low oiland gas demand and price levels, the failure ofnew
products toachieve market acceptance, delayed orcancelled customer orders, product obsolescence resulting from poor industry conditions ornew
Preview truncated — download the full document for the complete content.
investor_presentation
28 Pages
Karyopharm Therapeutics Investor Presentation — May 2022
investor_presentation
39 Pages
Karyopharm Therapeutics Inc.